Sinha Ray A, Errabelli P, Mareedu N, Lathiya MK. Renal tubular acidosis complication of non-steroidal anti-inflammatory drugs induced interstitial nephritis and its complete resolution with steroids: A case report. World J Nephrol 2026; 15(1): 117950 [DOI: 10.5527/wjn.v15.i1.117950]
Corresponding Author of This Article
Abhisekh Sinha Ray, Assistant Professor, Department of Nephrology and Critical Care, Creighton University School of Medicine, 3219 Central Ave #200, Kearney, NE 68847, United States. abhisekh.sinharay@commonspirit.org
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Mar 25, 2026 (publication date) through Mar 14, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Sinha Ray A, Errabelli P, Mareedu N, Lathiya MK. Renal tubular acidosis complication of non-steroidal anti-inflammatory drugs induced interstitial nephritis and its complete resolution with steroids: A case report. World J Nephrol 2026; 15(1): 117950 [DOI: 10.5527/wjn.v15.i1.117950]
World J Nephrol. Mar 25, 2026; 15(1): 117950 Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.117950
Renal tubular acidosis complication of non-steroidal anti-inflammatory drugs induced interstitial nephritis and its complete resolution with steroids: A case report
Abhisekh Sinha Ray, Praveen Errabelli, Neeharik Mareedu, Maulik K Lathiya
Abhisekh Sinha Ray, Department of Nephrology and Critical Care, Creighton University School of Medicine, Kearney, NE 68847, United States
Praveen Errabelli, Department of Nephrology, Allina Health, St Paul, MN 55125, United States
Neeharik Mareedu, Department of Nephrology, UPMC Western Maryland, Cumberland, MD 21502, United States
Maulik K Lathiya, Department of Nephrology, Mayo Clinic, Rochester, MN 55905, United States
Author contributions: Sinha Ray A contributed to the original concept; Errabelli PK contributed to the submission; Sinha Ray A and Errabelli PK contributed to writing; Mareedu N and Maulik L contributed to review and revision.
Informed consent statement: Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Abhisekh Sinha Ray, Assistant Professor, Department of Nephrology and Critical Care, Creighton University School of Medicine, 3219 Central Ave #200, Kearney, NE 68847, United States. abhisekh.sinharay@commonspirit.org
Received: December 25, 2025 Revised: January 27, 2026 Accepted: February 26, 2026 Published online: March 25, 2026 Processing time: 85 Days and 3.3 Hours
Abstract
BACKGROUND
Non-steroidal anti-inflammatory drugs (NSAIDs) are extensively utilized for their analgesic and anti-inflammatory properties; however, their potential to induce renal adverse events remains a significant clinical concern. NSAID-induced interstitial nephritis (IN) and renal tubular acidosis (RTA) are rare but important complications of prolonged NSAID consumption. NSAID-induced RTA has been documented in limited case reports and usually resolves after stopping NSAIDs. However, our case shows a persistent, severe hypokalemia and hypophosphatemia linked to RTA from NSAID-induced IN, which resolved with steroid therapy.
CASE SUMMARY
A 70-year-old woman with a history of chronic NSAID use presented with weakness and palpitations. She had atrial fibrillation, severe hypokalemia (K 1.5 mmol/L), non-anion gap metabolic acidosis (HCO3 11 mmol/L, anion gap 11), hypophosphatemia (1.2 mg/dL), acute kidney injury (creatinine 2 mg/dL from 0.6), and rhabdomyolysis (creatine kinase 15620 U/L). Urinalysis showed pH 6.5, proteinuria, sterile pyuria, and a positive urine anion gap, indicating RTA. Electrolytes improved with supplementation and spironolactone, but didn’t normalize. At 4 weeks post-hospitalization, she still required supplementation; creatinine remained high. Renal biopsy revealed interstitial inflammation with active tubulitis, moderate interstitial fibrosis, and tubular atrophy. She was treated with 4 weeks of prednisone, leading to normalized electrolytes and improved creatinine (1 mg/dL), and the improvements were sustained 6 months post-treatment.
CONCLUSION
Our patient exhibited persistent metabolic disturbances even after the cessation of NSAID therapy. Despite moderate chronicity, active interstitial inflammation responded favorably to corticosteroid treatment, resulting in improved renal function and restoration of tubular function, with normalization of acid-base and electrolyte parameters.
Core Tip: This article underscores the importance of maintaining a high level of clinical suspicion for interstitial nephritis (IN) in case of non-steroidal anti-inflammatory drugs (NSAID)-induced persistent renal injury and dyselectrolytemia suggestive of renal tubular acidosis, and the critical role of biopsy in NSAID-induced IN. Role of steroids in drug-induced IN is debated; some study suggests their role only in early cases before fibrosis ensues. Our article emphasizes the potential role of steroids in persistent renal impairment and metabolic disturbances, even after discontinuation of NSAIDs, provided there is evidence of active interstitial inflammation and tubulitis on renal biopsy.